Clearside Biomedical, Inc. CLSD

Full chart Compare
Set alert

Price alert · CLSD

All alert types
0.41 USD 0.00 (+0.00%)

At closeOct 28, 2026, 4:00 PM EDT

Day range unavailable

52-week range unavailable

YTD
0.00%
1 year
0.00%

Revenue & Expenses

Revenue → Gross Profit: $1.51MGross Profit → Expenses: $1.51MRevenue → Cost of Revenue: $149.00KExpenses → Selling, General & Admin: $11.81MExpenses → Research & Development: $18.59MExpenses → Other Expenses: $5.47MNet Loss → Expenses: $34.35MGross Profit$1.51MNet Loss$34.35MCost of Revenue$149.00KExpenses$35.87MSelling, General & Admin$11.81MResearch & Development$18.59MOther Expenses$5.47MRevenue$1.66M

Latest period ending Dec 31, 2024 · select a line to chart its full history

CLSD annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
1.66M8.23M1.33M29.57M7.89M
1.51M7.87M1.12M29.57M7.89M
-28.88M-24.84M-30.28M-627.00K-18.21M
-34.35M-32.48M-32.95M376.00K-18.21M
-7.00-7.90-8.200.15-5.80
CLSD annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
20.02M28.92M48.26M30.44M17.55M
25.13M34.02M51.30M42.90M19.32M
63.98M49.93M40.70M4.93M10.56M
52.47M43.00M35.26M675.00K1.98M
-38.85M-15.91M10.61M37.98M8.76M
CLSD annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-24.70M-18.14M-13.37M-10.73M-13.12M
-638.00K-1.78M-246.00K0-55.00K
16.44M414.00K31.33M23.78M7.87M
-977.00K-1.78M-246.00K0-55.00K
-8.90M-19.50M17.72M13.05M-5.31M